Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of anemia in low-risk myelodysplastic syndromes with amifostine. In vitro testing of response.
Viniou N, Terpos E, Galanopoulos A, Kritikou-Griva E, Akel S, Michalis E, Apostolidou E, Georgiadou D, Kouraklis A, Parharidou A, Kokkini G, Symeonidis A, Anagnostopoulos NI, Christakis JI, Tasiopoulou A, Loukopoulos D, Yataganas X. Viniou N, et al. Among authors: kritikou griva e. Ann Hematol. 2002 Apr;81(4):182-6. doi: 10.1007/s00277-002-0442-y. Epub 2002 Mar 27. Ann Hematol. 2002. PMID: 11976818 Clinical Trial.
Treatment of patients with myelodysplastic syndrome with amifostine.
Galanopoulos A, Kritikou-Griva E, Gligori J, Michalis E, Grigoraki V, Marinakis T, Kakkas J, Tasiopoulou A, Anagnostopoulos NI. Galanopoulos A, et al. Among authors: kritikou griva e. Leuk Res. 2001 Aug;25(8):665-71. doi: 10.1016/s0145-2126(01)00004-2. Leuk Res. 2001. PMID: 11397471 Clinical Trial.
High frequency of human leukocyte antigen class II DRB1*1602 haplotype in Greek patients with myelodysplastic syndrome and of DRB1*1501 in the low-risk subgroup.
Kritikou-Griva E, Spyropoulou-Vlachou M, Tsagarakis NJ, Goumakou E, Vrani V, Galanopoulos A, Papadhimitriou SI, Androutsos G, Paterakis G, Stavropoulos-Giokas C. Kritikou-Griva E, et al. Hum Immunol. 2012 Mar;73(3):278-81. doi: 10.1016/j.humimm.2011.12.013. Epub 2011 Dec 27. Hum Immunol. 2012. PMID: 22244918
"Bone marrow aspirate automated counts on hematology analyzers: formulating a scoring system based on hematology parameters, to discriminate reactive versus myelodysplastic syndrome-related bone marrows".
Tsagarakis NJ, Paterakis G, Papadhimitriou SI, Kritikou-Griva E, Goumakou E, Oudatzis G, Theodorakos I, Vasileiou P. Tsagarakis NJ, et al. Among authors: kritikou griva e. Int J Lab Hematol. 2019 Aug;41(4):542-549. doi: 10.1111/ijlh.13049. Epub 2019 May 18. Int J Lab Hematol. 2019. PMID: 31102331
Green bodies: Inclusions in a critically ill COVID-19 patient.
Chaliori I, Tsagarakis NJ, Chaniotaki S, Androutsos G, Liakopoulos D, Kritikou-Griva E. Chaliori I, et al. Among authors: kritikou griva e. EJHaem. 2021 May 4;2(3):637. doi: 10.1002/jha2.197. eCollection 2021 Aug. EJHaem. 2021. PMID: 34226898 Free PMC article. No abstract available.